Suchergebnisse - "Van Tassell, Benjamin"

PubPharm (22)

1

Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials

enthalten in: bioRxiv.org | 2023

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +20

2

Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes

enthalten in: European journal of internal medicine | 2022

von INSPIRATION INVESTIGATORS | Sadeghipour, P. | Talasaz, A. | +30

3

Targeting the NLRP3 inflammasome in cardiovascular diseases

enthalten in: Pharmacology & therapeutics | 2022

von Toldo, S. | Mezzaroma, E. | Buckley, L. | +5

4

Atorvastatin versus placebo in patients with covid-19 in intensive care : randomized controlled trial

enthalten in: BMJ (Clinical research ed.) | 2022

von INSPIRATION-S Investigators | Bikdeli, B. | Talasaz, A. | +64

5

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit : 90-Day Results from the INSPIRATION Randomized Trial

enthalten in: Thrombosis and haemostasis | 2022

von Bikdeli, B. | Talasaz, A. | Rashidi, F. | +57

6

Use of novel antithrombotic agents for COVID-19 : Systematic summary of ongoing randomized controlled trials

enthalten in: Journal of thrombosis and haemostasis : JTH | 2021

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +13

7

Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19 : JACC State-of-the-Art Review

enthalten in: Journal of the American College of Cardiology | 2021

von Talasaz, A. | Sadeghipour, P. | Aghakouchakzadeh, M. | +20

UpdateOf: medRxiv. 2021 May 04;:. - PMID 33972948

8

Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19 : A Randomized Clinical Trial

enthalten in: JAMA | 2021

von Caricchio, R. | Abbate, A. | Gordeev, I. | +114

9

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

enthalten in: bioRxiv.org | 2021

von Talasaz, A. | Sadeghipour, P. | Kakavand, H. | +24

10

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID) : an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial

enthalten in: The Lancet. Rheumatology | 2021

von Cremer, P. | Abbate, A. | Hudock, K. | +51